Debon Securities released a research report on April 24 stating that it gave Langzi Shares (002612.SZ) an increase in holdings rating. The main reasons for the rating include: 1) medical and aesthetic business: endogenous growth+epitaxial mergers and acquisitions help scale expansion, and the self-developed product matrix is gradually enriched; 2) Apparel business: positioning the middle and high-end markets, and new retail accelerates the online business layout. (Mainichi Keizai Shimbun)
德邦证券4月24日发布研报称，给予朗姿股份（002612.SZ）增持评级。评级理由主要包括：1）医美业务：内生增长+外延并购协同助力规模扩张，自研产品矩阵逐步丰富；2）服装业务：定位中高端市场，新零售加速推进线上业务布局。（每日经济新闻）
Debon Securities released a research report on April 24 stating that it gave Langzi Shares (002612.SZ) an increase in holdings rating. The main reasons for the rating include: 1) medical and aesthetic business: endogenous growth+epitaxial mergers and acqu
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.